Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2017/07/008965
CTRI/2017/07/008965CompletedPhase 2

Clinical evaluation of Siddha drug MADHUMEGA KUDINEER (Internal) in the treatment of SINAIPAINEERKATTI (Polycystic Ovarian Syndrome)

Self0 sites10 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Self
Enrollment
10
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •1.Patients who are having the clinical symptoms of Oligomenorrhoea (or) Amenorrhoea (or) obesity or infertility with polycystic changes in ovaries.
  • •2.USG pelvis showing polycystic ovaries.
  • •3.Patient willing to participate in trial and signing in consent form

Exclusion Criteria

  • •1.H/O hypertension
  • •2.Ovarian cancer
  • •3.Pregnancy and lactation
  • •4.H/O thyroid dysfunction
  • •5.Patient with any serious illness
  • •6.Fibroid uterus

Investigators

Sponsor
Self

Similar Trials

Not yet recruiting
Phase 2
Pre clinical and clinical study of Kukkil chooranam(Internal) and Thuvara ennai(External) in the treatment of Varicose ulcer(Nalavibatha viranam)
CTRI/2017/05/008584ATIONAL INSTITUTE OF SIDDHA40
Not yet recruiting
Phase 2
Siddha drug veppampoo Mathirai for Blood pressure
CTRI/2022/02/040005Self
Completed
Phase 1
Siddha medicine for HIV
CTRI/2008/091/000021daykumar Ranga, JNCASR, Bangalore
Not yet recruiting
Phase 3
ayuruvi Nei in the treatment of Varal moolam
CTRI/2020/02/023354ational institute of Siddha
Completed
Phase 3
Treatment for Kanakadi (Urticaria) by using Gandhaga rasayanam and Arugan thylam
CTRI/2022/11/047671ational Institute of Siddha30